Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 6, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.8K

New Developments in Biomarkers for Atopic Dermatitis.

Judith L Thijs1, Wouter van Seggelen2, Carla Bruijnzeel-Koomen3

  • 1Department of Dermatology and Allergology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. j.thijs@umcutrecht.nl.

Journal of Clinical Medicine
|August 5, 2015
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin-Homing T Cells of Atopic Dermatitis Patients.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

European consensus recommendations for nummular eczema: A modified Delphi study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trial.

The Journal of dermatological treatment·2026
Same author

A Real-world Meta-analysis Study of Disease Severity in European Patients Who Received Baricitinib for Atopic Dermatitis: Data from BioDay, SCRATCH and TREATgermany.

Acta dermato-venereologica·2026
Same author

Long-term efficacy of abrocitinib in patients with moderate-to-severe atopic dermatitis to 2 years.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA<sup>2</sup>LEN ADCARE statement paper.

The World Allergy Organization journal·2026

Biomarkers are crucial for understanding atopic dermatitis (AD) and improving patient care. A panel of serum biomarkers, alongside non-invasive methods like saliva and capillary blood, offers enhanced disease assessment and personalized treatment strategies for AD.

Area of Science:

  • Biomedical science
  • Dermatology
  • Translational medicine

Background:

  • Biomarkers are increasingly vital in medicine for understanding disease, improving treatment efficacy and safety, and enabling precise clinical care.
  • Their application in atopic dermatitis (AD) is evolving, with potential uses in determining disease severity, diagnosis confirmation, and predicting treatment response.

Purpose of the Study:

  • To review the current use of biomarkers in atopic dermatitis (AD).
  • To discuss new developments and future perspectives for biomarkers in AD.
  • To explore alternative, non-invasive biomarker sources for improved user-friendliness.

Main Methods:

  • Review of existing literature on biomarkers in atopic dermatitis.
  • Discussion of current and emerging biomarker panels for disease severity assessment.
Keywords:
atopic dermatitisbiomarkersdisease severitydried blood spotseczemasalivastratification

More Related Videos

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation
02:36

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation

Published on: March 8, 2024

1.8K
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

5.3K

Related Experiment Videos

Last Updated: Apr 6, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.8K
Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation
02:36

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation

Published on: March 8, 2024

1.8K
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

5.3K
  • Exploration of alternative sample sources (saliva, capillary blood) versus traditional venous blood.

    • Main Results:

    • Serum thymus and activation-regulated chemokine (TARC) is currently a key biomarker for AD severity.
    • A panel of serum biomarkers is more effective for assessing AD severity than individual biomarkers.
    • Saliva and capillary blood offer promising non-invasive, cost-effective alternatives for biomarker analysis in AD.

    Conclusions:

    • Biomarkers are essential for advancing AD research and personalized medicine.
    • Individualized therapy based on a patient's biological signature will improve treatment efficacy.
    • Biomarkers will provide tools for predicting and monitoring therapeutic response in AD.